This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Boston Scientific Launches Rubicon™ Support Catheter In 0.035" And 0.018" Diameters

Stocks in this article: BSX

NATICK, Mass., March 6, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has begun the launch of its 0.035" and 0.018" Rubicon™ Support Catheter in the United States.  The device is designed to assist physicians with placement and support of guidewires that are used in peripheral vascular procedures to deliver stents and balloons to open blockages in the legs and other peripheral arteries.  Boston Scientific is also launching the 0.035" Rubicon Support Catheter in Europe to build on the momentum of the 0.018" size that was introduced in that region last fall.

Peripheral arterial disease (PAD) affects approximately 27 million people worldwide.  It can cause pain or cramping in the legs and hips due to lack of blood supply while walking or climbing stairs.  In some cases, the condition can become so severe it can lead to critical limb ischemia and the need for amputation.  The Rubicon Support Catheter was designed to help clinicians more easily reach blockages. 

"The Rubicon Support Catheter offers an outstanding combination of features," said Louis Lopez, M.D., St. Joseph's Hospital, Fort Wayne, Indiana.  "It offers the pushability, low-profile and flexibility needed for navigating through the types of challenging, complex lesions that physicians face in the peripheral vascular space."

The Rubicon Support Catheter had previously been available from Boston Scientific in a 0.014" diameter only, and by launching the 0.035 and 0.018" and sizes, Boston Scientific now offers physicians a full range of diameters to treat patients with peripheral arterial disease.  The Rubicon Support Catheter is also available in a variety of lengths including 65cm, 90cm, 135cm and 150cm. 

"Support catheters can help physicians treat more patients by facilitating the crossing of complex lesions," said Jeff Mirviss, president, Peripheral Interventions, Boston Scientific.  "By making a full range of diameters of Rubicon Support Catheters available, we are offering more choices to clinicians. The Rubicon Support Catheter is one of many new solutions that Boston Scientific has introduced to the market during the past two years and demonstrates our continued commitment to global leadership in Peripheral Intervention."

The Rubicon Support Catheter has received FDA 510(k) clearance and achieved CE Mark status. 

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,293.48 -93.73 -0.54%
S&P 500 2,018.48 -11.07 -0.55%
NASDAQ 4,675.21 -6.2870 -0.13%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs